Arcus Biosciences reports 26.7-month median survival and 59% response rate in Phase 2 cancer study with domvanalimab ...
Splenic Rupture Post-Caesarean Section. Open Journal of Nursing, 15, 848-862. doi: 10.4236/ojn.2025.1510061 . The spleen is a ...